Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease
- 1 April 2006
- journal article
- review article
- Published by Elsevier BV in Neuroscience Research
- Vol. 54 (4), 235-253
- https://doi.org/10.1016/j.neures.2005.12.015
Abstract
No abstract availableKeywords
This publication has 154 references indexed in Scilit:
- Natural oligomers of the amyloid-β protein specifically disrupt cognitive functionNature Neuroscience, 2004
- Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaquesEuropean Journal of Medicinal Chemistry, 2004
- MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's diseaseMagnetic Resonance in Medicine, 2004
- Oxidized neprilysin in aging and Alzheimer’s disease brainsBiochemical and Biophysical Research Communications, 2003
- Synthesis, aggregation, neurotoxicity, and secondary structure of various Aβ1–42 mutants of familial Alzheimer's disease at positions 21–23Biochemical and Biophysical Research Communications, 2002
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001
- Alzheimer’s Disease as Proteolytic Disorders: Anabolism and Catabolism of β-AmyloidNeurobiology of Aging, 1998
- Isolation, Chemical Characterization, and Quantitation of Aβ 3-Pyroglutamyl Peptide from Neuritic Plaques and Vascular Amyloid DepositsBiochemical and Biophysical Research Communications, 1997
- Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brainNeuroscience Letters, 1996
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991